Search research articles
Contact Us
Filters
Showing results (21-30 of 64) with videos related to
Page
of 7
Sort By:
Journal of Burn Care & Research : Official Publication of the American Burn Association
|
January 8, 2013
High risk but not always lethal: the effect of cirrhosis on thermally injured adults
Christopher J Burns, Kevin K Chung, James K Aden, et al.
Bioorganic & Medicinal Chemistry
|
January 30, 2002
Analogues of human parathyroid hormone (1-31)NH(2): further evaluation of the effect of conformational constraint on biological activity
Stephen M Condon, Shelley Darnbrough, Christopher J Burns, et al.
Organic & Biomolecular Chemistry
|
September 12, 2012
Synthesis and biological evaluation of a potent salicylihalamide A lactam analogue
Dan Balan, Christopher J Burns, Nicholas G Fisk, et al.
BMC Cancer
|
June 3, 2014
Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden
Khalid Abubaker, Rodney B Luwor, Hongjian Zhu, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
July 17, 2018
Therapeutic Effects of a TANK-Binding Kinase 1 Inhibitor in Germinal Center-Driven Collagen-Induced Arthritis
Cynthia Louis, Devi Ngo, Damian B D'Silva, et al.
Blood
|
September 22, 2005
The structural basis of Janus kinase 2 inhibition by a potent and specific pan-Janus kinase inhibitor
Isabelle S Lucet, Emmanuelle Fantino, Michelle Styles, et al.
Scientific Reports
|
May 7, 2015
BET inhibitors induce apoptosis through a MYC independent mechanism and synergise with CDK inhibitors to kill osteosarcoma cells
Emma K Baker, Scott Taylor, Ankita Gupte, et al.
Bioorganic & Medicinal Chemistry
|
September 10, 2015
Discovery and SAR of novel pyrazolo[1,5-a]pyrimidines as inhibitors of CDK9
Louisa J Phillipson, David H Segal, Tracy L Nero, et al.
Blood
|
April 14, 2010
CYT387, a novel JAK2 inhibitor, induces hematologic responses and normalizes inflammatory cytokines in murine myeloproliferative neoplasms
Jeffrey W Tyner, Thomas G Bumm, Jutta Deininger, et al.
Journal of Leukocyte Biology
|
November 14, 2008
Colony-stimulating factor-1 (CSF-1) delivers a proatherogenic signal to human macrophages
Katharine M Irvine, Melanie R Andrews, Manuel A Fernandez-Rojo, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 64) with videos related to
Sort By:
Page
of 7
Journal of Burn Care & Research : Official Publication of the American Burn Association
|
January 8, 2013
High risk but not always lethal: the effect of cirrhosis on thermally injured adults
Christopher J Burns, Kevin K Chung, James K Aden, et al.
Bioorganic & Medicinal Chemistry
|
January 30, 2002
Analogues of human parathyroid hormone (1-31)NH(2): further evaluation of the effect of conformational constraint on biological activity
Stephen M Condon, Shelley Darnbrough, Christopher J Burns, et al.
Organic & Biomolecular Chemistry
|
September 12, 2012
Synthesis and biological evaluation of a potent salicylihalamide A lactam analogue
Dan Balan, Christopher J Burns, Nicholas G Fisk, et al.
BMC Cancer
|
June 3, 2014
Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden
Khalid Abubaker, Rodney B Luwor, Hongjian Zhu, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
July 17, 2018
Therapeutic Effects of a TANK-Binding Kinase 1 Inhibitor in Germinal Center-Driven Collagen-Induced Arthritis
Cynthia Louis, Devi Ngo, Damian B D'Silva, et al.
Blood
|
September 22, 2005
The structural basis of Janus kinase 2 inhibition by a potent and specific pan-Janus kinase inhibitor
Isabelle S Lucet, Emmanuelle Fantino, Michelle Styles, et al.
Scientific Reports
|
May 7, 2015
BET inhibitors induce apoptosis through a MYC independent mechanism and synergise with CDK inhibitors to kill osteosarcoma cells
Emma K Baker, Scott Taylor, Ankita Gupte, et al.
Bioorganic & Medicinal Chemistry
|
September 10, 2015
Discovery and SAR of novel pyrazolo[1,5-a]pyrimidines as inhibitors of CDK9
Louisa J Phillipson, David H Segal, Tracy L Nero, et al.
Blood
|
April 14, 2010
CYT387, a novel JAK2 inhibitor, induces hematologic responses and normalizes inflammatory cytokines in murine myeloproliferative neoplasms
Jeffrey W Tyner, Thomas G Bumm, Jutta Deininger, et al.
Journal of Leukocyte Biology
|
November 14, 2008
Colony-stimulating factor-1 (CSF-1) delivers a proatherogenic signal to human macrophages
Katharine M Irvine, Melanie R Andrews, Manuel A Fernandez-Rojo, et al.
Page
of 7